Erle T Mast's Net Worth
$7.13 Million
Who is Erle T Mast?
Erle T Mast has an estimated net worth of $7.13 Million. This is based on reported shares across multiple companies, which include ZOGENIX, INC., Receptos, Inc., Clovis Oncology, Inc., Sienna Biopharmaceuticals, Inc., Pernix Sleep, Inc., and PHARMION CORP.
SEC CIK
Erle T Mast's CIK is 0001051411
Past Insider Trading and Trends
2012 was Erle T Mast's most active year for acquiring shares with 9 total transactions. Erle T Mast's most active month to acquire stocks was the month of November. 2015 was Erle T Mast's most active year for disposing of shares, totalling 43 transactions. Erle T Mast's most active month to dispose stocks was the month of February. 2008 saw Erle T Mast paying a total of $290,286.25 for 105,668 shares, this is the most they've acquired in one year. In 2015 Erle T Mast cashed out on 68,900 shares for a total of $8,707,438.35, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ZOGENIX, INC. No price found
InvestorErle T Mast owns 3,027 units of Stock Option (Right to Buy). Erle T Mast used to own units in Common Stock but no longer holds any shares there.acquired a total of 41,939 shares in ZOGENIX, INC. at a cost of $326,477.75, Erle also disposed a total of 20,745 shares of ZOGENIX, INC. equalling to $485,612.77.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.03K |
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
$19.02 | -$17,544.50 | 3.03K |
Scheduled
|
Feb 1
| ||
Form 4
|
—
|
0
|
$20.10 | -$179,696.00 | 3.03K |
Scheduled
|
Jan 19
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| -32.66% | -1.47K |
$42.08 | -$61,772.27 | 3.03K |
Nov 26
| |||
Form 4
| +48.50% | 1.47K |
$26.81 | $39,360.00 | 4.5K |
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| +44.85% | 7.5K |
$1.31 | $9,825.00 | 24.22K |
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| +148.79% | 10K |
$1.15 | $11,500.00 | 16.72K |
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
∞
| 6.72K |
$5.83 | $39,192.75 | 6.72K |
Dec 10 - Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Receptos, Inc. No price found
InvestorErle T Mast used to own units in Common Stock but no longer holds any shares there.acquired a total of 7,700 shares in Receptos, Inc. at a cost of $15,200.20, Erle also disposed a total of 7,700 shares of Receptos, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -7.70K |
—
|
—
|
0
|
Aug 25 - Aug 27
| |||
Form 4
| +2,466.67% | 7.4K |
—
|
—
| 7.7K |
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
∞
| 300 |
$50.67 | $15,200.20 | 300 |
Mar 14 - Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Clovis Oncology, Inc. No price found
Executive VP and CFOErle T Mast owns 135,583 units of Common Stock. In the year 2011 Erle T Mast filed a total of 16 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.16% | -3.00K |
$105.56 | -$316,679.30 | 135.58K |
Scheduled
|
Nov 2
| ||
Form 4
| -2.12% | -3.00K |
$90.22 | -$270,657.40 | 138.58K |
Scheduled
|
Oct 1
| ||
Form 4
| -2.07% | -3.00K |
$79.51 | -$238,518.03 | 141.58K |
Scheduled
|
Sep 1
| ||
Form 4
| -2.03% | -3.00K |
$85.97 | -$257,921.00 | 144.58K |
Scheduled
|
Aug 3
| ||
Form 4
| -1.99% | -3.00K |
$85.70 | -$257,085.00 | 147.58K |
Scheduled
|
Jul 1
| ||
Form 4
| -1.95% | -3.00K |
$88.78 | -$266,325.70 | 150.58K |
Scheduled
|
Jun 1
| ||
Form 4
| -1.92% | -3.00K |
$81.78 | -$245,346.14 | 153.58K |
Scheduled
|
May 1
| ||
Form 4
| -1.88% | -3.00K |
$71.25 | -$213,764.24 | 156.58K |
Scheduled
|
Apr 1
| ||
Form 4
| -5.34% | -9.00K |
$78.84 | -$709,553.54 | 159.58K |
Scheduled
|
Mar 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4
| -22.87% | -50.00K |
$52.78 | -$2,638,757.38 | 168.58K |
Dec 10 - Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +8.67% | 17.43K |
$13.00 |
—
| 218.58K |
Nov 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sienna Biopharmaceuticals, Inc. No price found
InvestorErle T Mast owns 6,700 units of Common Stock. In the year 2017 Erle T Mast filed a total of 3 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
∞
| 6.7K |
$15.00 | $100,500.00 | 6.7K |
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pernix Sleep, Inc. No price found
InvestorErle T Mast used to own units in Common Stock but no longer holds any shares there. From 2008 to 2013 Erle T Mast acquired a total of 268,514 shares in Pernix Sleep, Inc., Erle also disposed a total of 84,162 shares of Pernix Sleep, Inc. equalling to $110,202.50.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -39.16K |
—
|
—
|
0
|
Mar 6
| |||
Form 4
| +29.00% | 7.82K |
—
|
—
| 34.78K |
Dec 31
| |||
Form 4
| +36.27% | 57.41K |
—
|
—
| 215.69K |
Sep 30
| |||
Form 4
| +73.10% | 66.84K |
—
|
—
| 158.28K |
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
| +322.74% | 69.81K |
—
|
—
| 91.44K |
Apr 2
| |||
Form 4
| -18.78% | -5.00K |
$0.85 | -$4,258.50 | 21.63K |
Scheduled
|
Oct 3
| ||
Form 4
| -15.81% | -5.00K |
$1.11 | -$5,560.50 | 26.63K |
Scheduled
|
Aug 15
| ||
Form 4
| -13.65% | -5.00K |
$2.13 | -$10,633.50 | 31.63K |
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| -12.01% | -5.00K |
$2.65 | -$13,244.00 | 36.63K |
Scheduled
|
May 16
| ||
Form 4
| -10.72% | -5.00K |
$2.81 | -$14,066.00 | 41.63K |
Scheduled
|
Apr 1
| ||
Form 4
| -17.66% | -10.00K |
$3.01 | -$30,100.00 | 46.63K |
Scheduled
|
Feb 15
| ||
Form 4
| -15.01% | -10.00K |
$3.23 | -$32,340.00 | 56.63K |
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| +2.36% | 1.53K |
—
|
—
| 66.63K |
Mar 31
| |||
Form 4
| +19.56% | 10.65K |
—
|
—
| 65.1K |
Dec 31
| |||
Form 4
| +10.21% | 5.04K |
—
|
—
| 54.45K |
Sep 30
| |||
Form 4
| +39.00% | 13.86K |
—
|
—
| 49.41K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| +6,445.67% | 35K |
—
|
—
| 35.54K |
Mar 31
| |||
Form 4
|
∞
| 543 |
—
|
—
| 543 |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||